NCT06811857View on ClinicalTrials.gov

This Study Aims to Explore the Efficacy of Hyperbaric Oxygen in the Treatment of Flap Ischaemic Necrosis After Breast Cancer Surgery

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2027

Conditions

Flap NecrosisFlap Ischemia

Interventions

DEVICE

hyperbaric oxygen therapy and povidone-iodine wet compresses

The hyperbaric oxygen group receives 30-40 sessions of hyperbaric oxygen therapy (100% oxygen at a pressure of 2.0 ATA) and povidone-iodine wet compresses.

OTHER

wet compresses of povidone-iodine

Trial Locations (1)

510080

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors

lead

Guangdong Provincial People's Hospital

OTHER

NCT06811857 - This Study Aims to Explore the Efficacy of Hyperbaric Oxygen in the Treatment of Flap Ischaemic Necrosis After Breast Cancer Surgery | Biotech Hunter | Biotech Hunter